New Square Capital LLC Novartis Ag Transaction History

New Square Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$94.73 - $105.13 $13,072 - $14,507	138 Added 862.5%	154 $15,000
Q2 2023 Aug 03, 2023	SELL	$92.52 - $104.91 $2,313 - $2,622	-25 Reduced 60.98%	16 $1,000
Q1 2023 May 01, 2023	BUY	$80.03 - $92.81 $1,280 - $1,484	16 Added 64.0%	41 $3,000
Q1 2022 May 10, 2022	SELL	$80.11 - $90.62 $4,726 - $5,346	-59 Reduced 70.24%	25 $2,000
Q4 2021 Jan 26, 2022	SELL	$79.7 - $88.13 $1,992 - $2,203	-25 Reduced 22.94%	84 $7,000
Q1 2020 May 08, 2020	BUY	$70.67 - $99.01 $4,169 - $5,841	59 Added 118.0%	109 $9,000
Q4 2018 Jan 22, 2019	BUY	$73.66 - $82.02 $3,683 - $4,101	50 New	50 $4,000
Q1 2018 Apr 24, 2018	SELL	$70.39 - $84.15 $0 - $0	0 Closed	0 $0
Q4 2017 Jan 29, 2018	SELL	$72.33 - $77.64 $2,314 - $2,484	-32 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$74.14 - $77.27 $2,372 - $2,472	32	32 $3,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.